These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 20730250)

  • 1. Resistance to activated protein C and ischemic arterial disease in a young man.
    Menezes IA; Romani RF; Aoki YS; Abdo JC; Carvalho M
    Arq Bras Cardiol; 2010 Mar; 94(3):e31-3, e91-3. PubMed ID: 20730250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Brain stem ischemia in a boy with resistance to C activated protein and elevated lipoprotein A].
    Sameiro-Barreirinho M; Costa E; Moreira A; Barbot J; Barbot C; Santos M
    Rev Neurol; 1999 Jun 1-15; 28(11):1061-4. PubMed ID: 10390775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished response to activated protein C is not correlated with severity of peripheral arterial occlusive disease.
    Köppel H; Renner W; Krippl P; Wascher TC; Pilger E
    Clin Lab; 2004; 50(11-12):689-93. PubMed ID: 15575311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated protein C resistance, factor V Leiden and assessment of thrombotic risk.
    Gilmore R; Doyle M; Holden F; White B; O'Donnell J
    Ir Med J; 2008 Sep; 101(8):256-7. PubMed ID: 18990960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor V Leiden mutation and antiphospholipid syndrome: risk factors for atherosclerotic and arterial thromboembolic disease.
    Thakor AS; Shah D; Miller F; Gaunt ME
    J Vasc Interv Radiol; 2009 Aug; 20(8):1097-8. PubMed ID: 19574060
    [No Abstract]   [Full Text] [Related]  

  • 6. [Analysis of activated protein C resistance, factor V coagulation activity and gene polymorphisms in patients with venous thromboembolism].
    Han XM; Ren JF; Hao B; Cao WD; Liu XE; Hou LH; Guo ZP; Yu B; Wang XF; Ding QL; Yang LH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):612-6. PubMed ID: 17605877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischaemic stroke patients with heterozygous factor V Leiden present with multiple brain infarctions and widespread atherothrombotic disease.
    Haapaniemi E; Helenius J; Jakovljević D; Soinne L; Syrjälä M; Kaste M; Lassila R; Tatlisumak T
    Thromb Haemost; 2009 Jan; 101(1):145-50. PubMed ID: 19132201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Resistance to activated protein C in a patient with multiple myocardial infarctions and stroke--a case report].
    Kozłowska I; Krzystolik A; Rózański J; Nikodemska I; Kurowski M; Ciechanowski K
    Kardiol Pol; 2005 Feb; 62(2):151-2. PubMed ID: 15815800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired resistance to activated protein C (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolism.
    Elice F; Fink L; Tricot G; Barlogie B; Zangari M
    Br J Haematol; 2006 Aug; 134(4):399-405. PubMed ID: 16882132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated protein C resistance and factor V Leiden in Mexico.
    Majluf-Cruz A; Moreno-Hernández M; Ruiz-de-Chávez-Ochoa A; Monroy-García R; Majluf-Cruz K; Guardado-Mendoza R; Molina-Avila I; Isordia-Salas I; Corona-de la Peña N; Vargas-Vorackova F; Vela-Ojeda J; García-Chávez J
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):428-37. PubMed ID: 18160617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of thrombophilia based on coagulation and genetic studies].
    Bałszan-Kowalska I
    Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic risk factors and arterial thrombotic disease.
    Reiner AP; Siscovick DS; Rosendaal FR
    Thromb Haemost; 2001 Apr; 85(4):584-95. PubMed ID: 11341490
    [No Abstract]   [Full Text] [Related]  

  • 13. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.
    Bouaziz-Borgi L; Nguyen P; Hezard N; Musharrafieh U; Almawi WY; Mahjoub T
    Exp Mol Pathol; 2007 Dec; 83(3):480-3. PubMed ID: 17555744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis.
    Rehak M; Rehak J; Müller M; Faude S; Faude F; Siegemund A; Krcova V; Slavik L; Hasenclever D; Scholz M; Wiedemann P
    Thromb Haemost; 2008 May; 99(5):925-9. PubMed ID: 18449423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
    Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
    Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden mutation: an unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis.
    Thorarensen O; Ryan S; Hunter J; Younkin DP
    Ann Neurol; 1997 Sep; 42(3):372-5. PubMed ID: 9307261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms on the factor V gene in women with recurrent miscarriage and acquired APCR.
    Dawood F; Mountford R; Farquharson R; Quenby S
    Hum Reprod; 2007 Sep; 22(9):2546-53. PubMed ID: 17640947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V:Q506 mutation-resistance to activated protein C (APC): clinical implications with respect to family screening.
    Middeldorp S; van der Meer J
    Semin Thromb Hemost; 1998; 24(4):363-6. PubMed ID: 9763353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden.
    Graf LL; Welsh CH; Qamar Z; Marlar RA
    Am J Clin Pathol; 2003 Jan; 119(1):52-60. PubMed ID: 12520697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.